Table III.
Multivariate analysis | |||
---|---|---|---|
Characteristics | Hazard ratio | 95% CI | P-value |
CL_High/PD-L1_High | |||
Yes | 1.06E-09 | 0-0.43 | 0.01 |
No (ref) | |||
Stage | |||
I and II | 0.14 | 0.01–1.04 | 0.06 |
III and IV (ref) | |||
Grade | |||
1 and 2 | 0.3 | 0.03–1.88 | 0.2 |
3 (ref) | |||
Age (years) | |||
<60 | 0.58 | 0.05–6.12 | 0.64 |
≥60 (ref) | |||
CD8 | |||
>Median | 0.25 | 0.01–1.9 | 0.19 |
≤Median (ref) | |||
Stage | |||
I and II | 0.19 | 0.01–1.33 | 0.1 |
III and IV (ref) | |||
Grade | |||
1 and 2 | 0.22 | 0.06–1.85 | 0.22 |
3 (ref) | |||
Age (years) | |||
60 | 1.15 | 0.15–9.4 | 0.89 |
≥60 (ref) | |||
CD11c | |||
>Median | 0.21 | 0.01–2.34 | 0.21 |
≤Median (ref) | |||
Stage | |||
I and II | 0.16 | 0.01–1.28 | 0.09 |
III and IV (ref) | |||
Grade | |||
1 and 2 | 0.18 | 0.61–15.4 | 0.18 |
3 (ref) | |||
Age (years) | |||
<60 | 0.8 | 0.08–7.79 | 0.84 |
≥60 (ref) |